News of Note—APAC adds 50 jobs at Virginia site; New sterile injectable CMO forms

stock market
(Pixabay)  

> China's WuXi Biologics says it is adding commercial manufacturing to the integrated biologics conjugation solution center it is building in Wuxi, China. Release

> Two U.K. contract manufacturers, Cobra Biologics and Symbiosis Pharmaceutical Services, have invested £4.8 million in a collaboration on viral vector manufacturing. Release 

> After making upgrades, API maker AMPAC Fine Chemicals has reopened a plant in Petersburg, Virginia, that has a 50,000-gallon capacity and will add 150 jobs. Release 

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.

> A new CMO has come on the scene with plans to build a $30 million sterile drug manufacturing facility on the West Coast. Story

Read more on